Literature DB >> 13680821

Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases.

Adelina Jimenez-Arellanes1, Mariana Meckes, Raquel Ramirez, Javier Torres, Julieta Luna-Herrera.   

Abstract

The increase of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) demands the search for alternative antimycobacterial drugs. The aim of this study was to evaluate plants used in Mexican traditional medicine to treat respiratory diseases for activity against MDR-TB. A group of 22 plants was screened for activity against Mycobacterium tuberculosis H37Rv and Mycobacterium avium at concentrations from 50 to 200 microg/mL. The antimycobacterial effect was determined by a microcolorimetric assay with Alamar blue dye. None of the aqueous extracts had antimycobacterial activity. Hexane extracts from Artemisia ludoviciana, Chamaedora tepejilote, Lantana hispida, Juniperus communis and Malva parviflora, and methanol extracts from Artemisia ludoviciana and Juniperus communis inhibited the growth of Mycobacterium tuberculosis. Mycobacterium avium was inhibited by Juniperus communis hexane extract and by Malva parviflora methanol extract. The active extracts were tested against monoresistant variants of Mycobacterium tuberculosis H37Rv (isoniazid, rifampin, streptomycin and ethambutol resistant) and the hexane extract of Lantana hispida showed the best activity. Lantana hispida hexane extract was also active against a group of MDR-TB clinical isolates. In contrast, it did not inhibit the growth of non-tuberculous mycobacteria. The hexane extract of Lantana hispida was fractionated by column chromatography and one of its fractions (FVI) inhibited the growth of all the MDR-TB clinical isolates at concentrations up to 25 microg/mL. This study supports the fact that selecting plants by ethnobotanical criteria enhances the probability of finding species with activity against mycobacteria, and our results point to Lantana hispida as an important source of potential compounds against MDR-TB. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680821     DOI: 10.1002/ptr.1377

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  29 in total

1.  Genome-wide expression profiling of the response to linezolid in Mycobacterium tuberculosis.

Authors:  Junchao Liang; Xudong Tang; Na Guo; Kaiyu Zhang; Aizhen Guo; Xiuping Wu; Xuelin Wang; Zhenhong Guan; Lihui Liu; Fengge Shen; Mingxun Xing; Liqiang Liu; Lei Li; Lu Yu
Journal:  Curr Microbiol       Date:  2012-03-03       Impact factor: 2.188

2.  Pharmacognostic studies of stem, roots and leaves of Malva parviflora L.

Authors:  Shehla Akbar; Uzma Hanif; Jaffar Ali; Saiqa Ishtiaq
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

3.  Microarray analysis of the chelerythrine-induced transcriptome of Mycobacterium tuberculosis.

Authors:  Junchao Liang; Fanli Zeng; Aizhen Guo; Liqiang Liu; Na Guo; Lei Li; Jing Jin; Xiuping Wu; Mingyuan Liu; Dan Zhao; Yang Li; Qi Jin; Lu Yu
Journal:  Curr Microbiol       Date:  2010-12-19       Impact factor: 2.188

4.  The anti-mycobacterial activity of Lantana camara a plant traditionally used to treat symptoms of tuberculosis in South-western Uganda.

Authors:  Claude Kirimuhuzya; Paul Waako; Moses Joloba; Olwa Odyek
Journal:  Afr Health Sci       Date:  2009-03       Impact factor: 0.927

5.  EPR interpretation, magnetism and biological study of a Cu(II) dinuclear complex assisted by a schiff base precursor.

Authors:  Kuheli Das; Chiranjit Patra; Chandana Sen; Amitabha Datta; Chiara Massera; Eugenio Garribba; Mohamed Salah El Fallah; Belete B Beyene; Chen-Hsiung Hung; Chittaranjan Sinha; Tulin Askun; Pinar Celikboyun; Daniel Escudero; Antonio Frontera
Journal:  J Biol Inorg Chem       Date:  2016-12-30       Impact factor: 3.358

6.  Efficacy of Artemisia afra phytotherapy in experimental tuberculosis.

Authors:  Siyabulela Ntutela; Pete Smith; Lungile Matika; James Mukinda; Hiram Arendse; Nasiema Allie; D Mark Estes; Wilfred Mabusela; Peter Folb; Lafras Steyn; Quinton Johnson; William R Folk; James Syce; Muazzam Jacobs
Journal:  Tuberculosis (Edinb)       Date:  2009-12       Impact factor: 3.131

7.  What's in a Name? Can Mullein Weed Beat TB Where Modern Drugs Are Failing?

Authors:  Eibhlín McCarthy; Jim M O'Mahony
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-19       Impact factor: 2.629

Review 8.  Mexican Plants and Derivates Compounds as Alternative for Inflammatory and Neuropathic Pain Treatment-A Review.

Authors:  Geovanna N Quiñonez-Bastidas; Andrés Navarrete
Journal:  Plants (Basel)       Date:  2021-04-25

9.  Antimicrobial activities of the methanol extract and compounds from the twigs of Dorstenia mannii (Moraceae).

Authors:  Armelle T Mbaveng; Victor Kuete; Bathelemy Ngameni; Veronique P Beng; Bonaventure T Ngadjui; Jacobus J Marion Meyer; Namrita Lall
Journal:  BMC Complement Altern Med       Date:  2012-06-29       Impact factor: 3.659

10.  Anti-Helicobacter pylori Activity of Artemisia ludoviciana subsp. mexicana and Two of Its Bioactive Components, Estafiatin and Eupatilin.

Authors:  Juan Francisco Palacios-Espinosa; Pablo Noé Núñez-Aragón; Erika Gomez-Chang; Edelmira Linares; Robert Bye; Irma Romero
Journal:  Molecules       Date:  2021-06-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.